BSE - Delayed Quote INR

Aurobindo Pharma Limited (AUROPHARMA.BO)

1,150.65

-4.35

(-0.38%)

At close: June 13 at 3:58:28 PM GMT+5:30

Acadia Pharmaceuticals Again Prevails in Appeal Upholding Patent for Parkinson's Drug

Acadia Pharmaceuticals (ACAD) late Monday said the US Court of Appeals for the Federal Circuit has u

PREMIUM
MT Newswires 5 days ago

AUROPHARMA.NS
Aurobindo Pharma Ltd (BOM:524804) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Aurobindo Pharma Ltd (BOM:524804) reports robust financial performance with significant growth in European and specialty segments, despite challenges in key markets.

GuruFocus.com 18 days ago

AUROPHARMA.NS
Aurobindo Pharma Ltd (BOM:524804) Q3 2025 Earnings Call Highlights: Record Revenue and ...

Aurobindo Pharma Ltd (BOM:524804) reports its highest ever quarterly revenue, driven by strong US and European sales, while navigating operational challenges and market pressures.

GuruFocus.com 4 months ago

AUROPHARMA.NS

Performance Overview

Return	AUROPHARMA.BO	S&P BSE SENSEX (^BSESN)
YTD	-13.77%	+3.81%
1-Year	-8.29%	+5.61%
3-Year	+125.33%	+53.50%